FluxWear, Inc.

FluxWear, Inc. manufactures SHIFT, a wearable neuromodulation device designed for non-invasive pain management and mental health applications. SHIFT delivers low-level pulsing magnetic fields (PEMF technology) through microcoil emitters positioned in a comfortable, hat-like wearable form factor. The device operates at very low magnetic field intensities (earth-level) and delivers a 25-minute treatment session activated by a single button on a portable controller. Clinical applications include chemotherapy-induced peripheral neuropathy (CIPN), chronic pain reduction, anxiety management, focus improvement, and OCD symptom relief. Users report greater than 50% pain reduction with rapid onset (approximately 25 minutes). SHIFT is FDA Class I registered and employs proprietary pulse train and emitter sequencing algorithms for whole-brain stimulation without user-configurable settings. The device is available in multiple color options and is designed for home use and portability. FluxWear conducts clinical trials and has received recognition including NY Awards, Muse Awards, and an Innovator of the Year nomination from the Orange County Business Journal. The company was founded following the autoimmune condition diagnosis of co-founder Nadia in 2017.